Blunted expression of miR-199a-5p in regulatory T cells of patients with chronic obstructive pulmonary disease compared to unaffected smokers

Clinical and Experimental Immunology

Volumn 177, Issue 1, 2014, Pages 341-352

  Chatila, W M ^a   Criner, G J ^a   Hancock, W W ^b   Akimova, T ^b   Moldover, B ^c   Chang, J K ^a   Cornwell, W ^a   Santerre, M ^a   Rogers, T J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c B Tech Consulting Ltd   (United States)

Author keywords

FoxP3; MicroRNAs; MiR 199a 5p; Smoking; T cells

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; MICRORNA; MICRORNA 199A 5P; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL POPULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; EFFECTOR CELL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING;

FOXP3; MICRORNAS; MIR-199A-5P; SMOKING; T CELLS;

ADULT; CELLS, CULTURED; CHRONIC DISEASE; DOWN-REGULATION; FEMALE; HUMANS; MALE; MICROARRAY ANALYSIS; MICRORNAS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SIGNAL TRANSDUCTION; SMOKING; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84904243956     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12325     Document Type: Article

References (38)

1. MacNee W, Tuder RM. New paradigms in the pathogenesis of chronic obstructive pulmonary disease I. Proc Am Thorac Soc 2009; 6:527-531.
2. Agusti A, Sobradillo P, Celli B. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. Am J Respir Crit Care Med 2011; 183:1129-1137.
3. Mercado N, Thimmulappa R, Thomas CM etal. Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress. Biochem Biophys Res Commun 2011; 406:292-298.
4. Adenuga D, Yao H, March TH, Seagrave J, Rahman I. Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke. Am J Respir Cell Mol Biol 2009; 40:464-473.
5. Smyth LJ, Starkey C, Vestbo J, Singh D. CD4-regulatory cells in COPD patients. Chest 2007; 132:156-163.
6. Barcelo B, Pons J, Ferrer JM, Sauleda J, Fuster A, Agusti AG. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur Respir J 2008; 31:555-562.
7. Hou J, Sun Y, Hao Y etal. Imbalance between subpopulations of regulatory T cells in COPD. Thorax 2013; 68:1131-1139.
8. Plumb J, Smyth LJ, Adams HR, Vestbo J, Bentley A, Singh SD. Increased T-regulatory cells within lymphocyte follicles in moderate COPD. Eur Respir J 2009; 34:89-94.
9. Lee SH, Goswami S, Grudo A etal. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007; 13:567-569.
10. Isajevs S, Taivans I, Strazda G etal. Decreased FOXP3 expression in small airways of smokers with COPD. Eur Respir J 2009; 33:61-67.
11. Moodley Y, Tan D. Impaired function of T-regulatory cells in COPD. Am J Respir Crit Care Med 2012; 185:A4544.
12. Wang H, Peng W, Weng Y etal. Imbalance of Th17/Treg cells in mice with chronic cigarette smoke exposure. Int Immunopharmacol 2012; 14:504-512.
13. Quintana FJ, Basso AS, Iglesias AH etal. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008; 453:65-71.
14. Dang EV, Barbi J, Yang HY etal. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 2011; 146:772-784.
15. Sethi A, Kulkarni N, Sonar S, Lal G. Role of miRNAs in CD4 T cell plasticity during inflammation and tolerance. Front Genet 2013; 4:1-13.
16. Liang TJ, Qin CY. The emerging role of microRNAs in immune cell development and differentiation. APMIS 2009; 117:635-643.
17. Liston A, Lu LF, O'Carroll D, Tarakhovsky A, Rudensky AY. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 2008; 205:1993-2004.
18. Stahl HF, Fauti T, Ullrich N etal. miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression. PLOS ONE 2009; 4:e7158.
19. Lu LF, Boldin MP, Chaudhry A etal. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010; 142:914-929.
20. Rabe KF, Hurd S, Anzueto A etal. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-555.
21. Akimova T, Ge G, Golovina T etal. Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs. Clin Immunol 2010; 136:348-363.
22. miRWalk. The database on predicted and validated microRNA targets. 2013. Available at: http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/micrornapredictedtarget.html (accessed November 2013).
23. Sadlon TJ, Wilkinson BG, Pederson S etal. Genome-wide identification of human FOXP3 target genes in natural regulatory T cells. J Immunol 2010; 185:1071-1081.
24. Kim S, Lee UJ, Kim MN etal. MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). J Biol Chem 2008; 283:18158-18166.
25. Chatila W, Aksoy M, Arguello V, Ji R, Kelsen S. COPD is not caused by a defect in T-regulatory cell infiltration into the lung. Am J Respir Crit Care Med 2008; 177:A874.
26. Retamales I, Elliott WM, Meshi B etal. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001; 164:469-473.
27. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57:847-852.
28. Magrelli A, Azzalin G, Salvatore M etal. Altered microRNA expression patterns in hepatoblastoma patients. Transl Oncol 2009; 2:157-163.
29. Dai L, Gu L, Di W. MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKKbeta/NF-kappaB pathway and reduced interleukin-8 expression. Mol Hum Reprod 2012; 18:136-145.
30. Zhang Y, Fan KJ, Sun Q etal. Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-beta signalling pathway. Nucleic Acids Res 2012; 40:9286-9297.
31. Lu L, Ma J, Wang X etal. Synergistic effect of TGF-beta superfamily members on the induction of Foxp3+ Treg. Eur J Immunol 2010; 40:142-152.
32. Yoshioka Y, Ono M, Osaki M, Konishi I, Sakaguchi S. Differential effects of inhibition of bone morphogenic protein (BMP) signalling on T-cell activation and differentiation. Eur J Immunol 2012; 42:749-759.
33. He J, Xu Q, Jing Y etal. Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation. EMBO Rep 2012; 13:1116-1122.
34. Kirkham PA, Barnes PJ. Oxidative stress in COPD. Chest 2013; 144:266-273.
35. Sakurai K, Furukawa C, Haraguchi T etal. MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers. Cancer Res 2011; 71:1680-1689.
36. Chen ZH, Kim HP, Sciurba FC etal. Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLOS ONE 2008; 3:e3316.
37. Mizuno S, Bogaard HJ, Gomez-Arroyo J etal. MicroRNA-199a-5p is associated with hypoxia-inducible factor-1alpha expression in lungs from patients with COPD. Chest 2012; 142:663-672.
38. Rahman MK, Offord CP, Khanna S etal. Regulatory T cell kinetics in the peripheral blood of patients with Crohn's disease. Hum Immunol 2013; 74:145-150.